The HIV Patient Management Simulator II: Individualizing Therapy to Meet Your Patients’ Needs

Highly effective antiretroviral therapy (ART) has transformed HIV from a rapidly deteriorating condition to a complex, chronic condition, with individuals now expecting to live a normal lifespan. With longer survival, patients will be exposed to antiretroviral agents for decades. Therefore, maximizing the safety and tolerability of therapies, as well as preventing resistance, is a high priority. Significant progress has been made toward simplified, single-tablet regimens, optimizing the long-term safety and tolerability of therapy. Despite these advances, clinicians face challenges when selecting and maintaining therapy. In this interactive activity, HIV Patient Management Simulator II, expert faculty will use a case-based approach to discuss various aspects of HIV management, including optimal starting regimens for treatment-naïve patients, as well as the role of switching therapy in treatment-experienced patients. They also will integrate updated guideline recommendations and evidence from recent clinical trials to identify best practices in the management of HIV.
 
Educational Partner: Vindico Medical Education
 
Simulation-services provided by: Syandus
 
Endorsed by: American Academy of HIV Medicine

Medium: Multimedia

Commerical Support: This activity is supported by an educational grant from ViiV Healthcare.

Target Audience

The intended audience for this activity is infectious disease physicians, family physicians, primary care physicians, internal medicine physicians, nurses, pharmacists and other health care professionals involved in the treatment of patients with HIV.
Additional information
ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
For more information, please contact:
CME Coordinator Contact Email: 

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Differentiate HIV antiretroviral agents based on clinical safety and efficacy, barrier to resistance, and recommendations for use;
  • Review the impact of proper adherence on minimizing the emergence of resistance and optimizing patient outcomes;
  • Identify patients with HIV who may benefit from switching ART;
  • Implement treatment strategies for newly-diagnosed patients with HIV that reflect the latest clinical evidence, patient preference and characteristics, and potential DDIs;
  • Evaluate the latest clinical advances regarding simplified HIV treatment regimens in both newly-diagnosed and treatment-experienced patients;
  • Review the potential benefits of simplified HIV regimens on patient satisfaction and clinical outcomes.
Summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Activity opens: 
02/15/2018
Activity expires: 
02/14/2019
PEER REVIEWER
  Renslow Sherer, MD
  Professor of Medicine
  University of Chicago Medicine
  Chicago, IL
 
 
FACULTY
Richard A. Elion
Associate Clinical Professor of Medicine
George Washington University School of Medicine
Co-Director, DC Department of Health STD Research Program
Washington, DC
 
Mary Watson Montgomery, MD
Associate Physician
Infectious Diseases Division, Brigham & Women's Hospital
Instructor of Medicine
Harvard Medical School
Boston, MA
 
Paul E. Sax, MD
Clinical Director, Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, MA
 
Marc O. Siegel, MD
Associate Professor of Medicine
George Washington Medical Faculty Associates
Washington, DC
 

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Accreditation Statement
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Credit Designation Statement
The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 2 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Nurses and other healthcare professionals will receive a Certificate of Participation.  For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
 

Accreditation Period

Activity opens: 
02/15/2018
Activity expires: 
02/14/2019
Registration: To view this activity, you will need to visit the Healio website.
Click here to view the activity or if you are logged in click on the "Complete Activity" button!
 
Please login or create an account to proceed.